4/A
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-22-004197
CEO sold 50,000 shares at an average $66.84 ($3,341,903)
- CEO acquired 100,000 shares (option exercise)
- CEO gave 12,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2021-11-16 | Gift | −12,000 | 968,825 | D | ||
| Evans John M. CEO | 2022-01-31 | Sale | −801 | $63.79 | $51,096 | 968,024 | D |
| Evans John M. CEO | 2022-01-31 | Sale | −2,172 | $64.47 | $140,029 | 965,852 | D |
| Evans John M. CEO | 2022-01-31 | Sale | −3,177 | $65.49 | $208,062 | 962,675 | D |
| Evans John M. CEO | 2022-01-31 | Sale | −6,337 | $66.55 | $421,727 | 956,338 | D |
| Evans John M. CEO | 2022-01-31 | Sale | −13,535 | $67.44 | $912,800 | 942,803 | D |
| Evans John M. CEO | 2022-01-31 | Sale | −3,978 | $68.15 | $271,101 | 938,825 | D |
| Evans John M. CEO | 2022-01-31 | Option exercise | +100,000 | $1.03 | $103,000 | 1,038,825 | D |
| Evans John M. CEO | 2022-01-31 | Sale | −300 | $63.45 | $19,035 | 182,700 | I |
| Evans John M. CEO | 2022-01-31 | Sale | −1,615 | $64.46 | $104,103 | 181,085 | I |
| Evans John M. CEO | 2022-01-31 | Sale | −1,900 | $65.55 | $124,545 | 179,185 | I |
| Evans John M. CEO | 2022-01-31 | Sale | −4,105 | $66.48 | $272,900 | 175,080 | I |
| Evans John M. CEO | 2022-01-31 | Sale | −9,408 | $67.43 | $634,381 | 165,672 | I |
| Evans John M. CEO | 2022-01-31 | Sale | −2,672 | $68.16 | $182,124 | 163,000 | I |
| Derivatives | |||||||
| Evans John M. CEO | 2022-01-31 | Option exercise · Stock Option (Right to Buy) | −100,000 | 284,345 | D | ||
| Evans John M. CEO | 2022-01-31 | Grant or award · Stock Option (Right to Buy) | +112,500 | 112,500 | D | ||
| Open-market sales · 50,000 sh · avg $66.84 · $3,341,903 | |||||||
Loading xslF345X03/doc4a.xml…